Autologous Endothelial Progenitor Cell Therapy

· National University Hospital, Singapore

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Endothelial Progenitor Cell Therapy, covering 2021-01-19 to 2021-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis [Phase 3]